{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:03:43Z","timestamp":1786637023912,"version":"build-2736575974"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:p>\n                    Due to the limitations of traditional observational studies, investigating the association between inflammatory factors and inflammatory bowel disease (IBD) remains challenging. In this study, we employed Mendelian randomization (MR) combined with meta-analysis to assess the causal relationship between 91 inflammatory factors and IBD. We selected genome-wide association study (GWAS) data for inflammatory factors and IBD from GWAS databases and conducted 2-sample MR analyses using the inverse-variance weighted (IVW) method, MR-Egger regression, and weighted median estimator. The MR analyses were performed for 91 inflammatory factors with IBD outcome data from 2 different databases. Subsequently, a meta-analysis of the main IVW results was conducted, followed by multiple corrections of the meta-analysis results. Conduct MR analysis between inflammatory factors and subtypes of IBD (Crohn disease and ulcerative colitis [UC]), followed by reverse causality validation of positive inflammatory factors with IBD and its subtype outcome data. In the IVW analysis of the 91 inflammatory factors with IBD outcome data from the GWAS catalog database, C-X-C motif chemokine 9 (CXCL9) was found to be positively associated with the risk of IBD (OR\u2005=\u20051.24, 95% CI\u2005=\u20051.09\u20131.41,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001). Similarly, in the IVW analysis with IBD outcome data from the IEU database, CXCL9 was also positively associated with the risk of IBD (OR\u2005=\u20051.76, 95% CI\u2005=\u20051.12\u20132.76,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.015). Meta-analysis and multiple corrections showed a significant association between CXCL9 and IBD (OR\u2005=\u20051.27, 95% CI\u2005=\u20051.12\u20131.44,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001). In the MR analysis of IBD subtypes, the inflammatory factor CXCL9 showed a significant causal association with UC using the IVW method (OR\u2005=\u20051.77, 95% CI = 1.39\u20132.44,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0004), with a\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    -value of .038 after multiple testing correction. However, no significant causal association was observed between CXCL9 and Crohn disease\u2005=\u20053.28). In the reverse MR analysis, no causal effect of IBD and UC on CXCL9 was found. CXCL9 exhibits a causal relationship with IBD, functioning as a disease-progression risk factor that elevates UC risk, suggesting potential therapeutic targets for alleviating symptoms and slowing progression in UC patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042988","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:00:45Z","timestamp":1751295645000},"page":"e42988","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between inflammatory factors and inflammatory bowel disease: A bidirectional Mendelian randomization study combined with meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiang","family":"Ji","sequence":"first","affiliation":[{"name":"Anorectal Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afen","family":"Wu","sequence":"additional","affiliation":[{"name":"Anorectal Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Zha","sequence":"additional","affiliation":[{"name":"Anorectal Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0778-1489","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Anorectal Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis.","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease.","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease.","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease.","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/gut.2006.116467","article-title":"Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.","volume":"56","author":"Kugathasan","year":"2007","journal-title":"Gut"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40265-020-01460-3","article-title":"Vedolizumab and extraintestinal manifestations in inflammatory bowel disease.","volume":"81","author":"Hanzel","year":"2021","journal-title":"Drugs"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/gast.2001.27154","article-title":"CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn\u2019s disease.","volume":"121","author":"Papadakis","year":"2001","journal-title":"Gastroenterology"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"e16442","DOI":"10.1371\/journal.pone.0016442","article-title":"CCL25\/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.","volume":"6","author":"Wurbel","year":"2011","journal-title":"PLoS One"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"154658","DOI":"10.1016\/j.phymed.2023.154658","article-title":"Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: network pharmacology analysis and experimental evidence.","volume":"111","author":"Duan","year":"2023","journal-title":"Phytomedicine"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","article-title":"Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes.","volume":"97","author":"Arabpour","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"e13536","DOI":"10.1111\/srt.13536","article-title":"Exploration of the biomarkers of comorbidity of psoriasis with inflammatory bowel disease and their association with immune infiltration.","volume":"29","author":"Ding","year":"2023","journal-title":"Skin Res Technol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/cells11030314","article-title":"Expression of fibrosis-related genes in liver and kidney fibrosis in comparison to inflammatory bowel diseases.","volume":"11","author":"Jerala","year":"2022","journal-title":"Cells"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2022.09.024","article-title":"Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications.","volume":"164","author":"Nagata","year":"2023","journal-title":"Gastroenterology"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"e179472","DOI":"10.1172\/JCI179472","article-title":"TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn\u2019s disease.","volume":"134","author":"Zhang","year":"2024","journal-title":"J Clin Invest"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s15010-024-02446-z","article-title":"The role of vitamin D in the prevention and treatment of tuberculosis: a meta-analysis of randomized controlled trials.","volume":"53","author":"Meng","year":"2024","journal-title":"Infection"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/187153007780832109","article-title":"CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.","volume":"7","author":"Singh","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JS9.0000000000001840","article-title":"The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.","volume":"111","author":"Xu","year":"2024","journal-title":"Int J Surg"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacc.2020.10.048","article-title":"Diet-derived circulating antioxidants and risk of coronary heart disease: a Mendelian randomization study.","volume":"77","author":"Luo","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R24-20260813","doi-asserted-by":"crossref","first-page":"e0236904","DOI":"10.1371\/journal.pone.0236904","article-title":"Coffee consumption and risk of breast cancer: a Mendelian randomization study.","volume":"16","author":"Ellingjord-Dale","year":"2021","journal-title":"PLoS One"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"1160993","DOI":"10.3389\/fcimb.2023.1160993","article-title":"Causal effects of gut microbiota on the risk of periodontitis: a two-sample Mendelian randomization study.","volume":"13","author":"Luo","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JS9.0000000000001840","article-title":"The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.","volume":"111","author":"Xu","year":"2025","journal-title":"Int J Surg"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R30-20260813","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1189\/jlb.5A0717-302","article-title":"A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines.","volume":"102","author":"Zhao","year":"2017","journal-title":"J Leukoc Biol"},{"key":"R31-20260813","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function.","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"R32-20260813","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"R33-20260813","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"key":"R34-20260813","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/gut.48.3.326","article-title":"Increased expression of IL-16 in inflammatory bowel disease.","volume":"48","author":"Seegert","year":"2001","journal-title":"Gut"},{"key":"R35-20260813","doi-asserted-by":"crossref","first-page":"1168188","DOI":"10.3389\/fimmu.2023.1168188","article-title":"Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study.","volume":"14","author":"Fang","year":"2023","journal-title":"Front Immunol"},{"key":"R36-20260813","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10787-023-01136-w","article-title":"Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"R37-20260813","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12920-024-01826-6","article-title":"Proteome-wide mendelian randomization investigates potential associations in heart failure and its etiology: emphasis on PCSK9.","volume":"17","author":"Lin","year":"2024","journal-title":"BMC Med Genomics"},{"key":"R38-20260813","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/JS9.0000000000000416","article-title":"A commentary on \u201cBone grafting for femoral head necrosis in the past decade: a systematic review and network meta-analysis\u201d (Int J Surg. 2023;10.1097. doi: 10.1097\/JS9.0000000000000231).","volume":"110","author":"Cao","year":"2024","journal-title":"Int J Surg"},{"key":"R39-20260813","doi-asserted-by":"crossref","first-page":"e0245713","DOI":"10.1371\/journal.pone.0245713","article-title":"Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.","volume":"16","author":"Konstantinidis","year":"2021","journal-title":"PLoS One"},{"key":"R40-20260813","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1189\/jlb.1RU0716-327R","article-title":"Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance.","volume":"101","author":"Kulkarni","year":"2017","journal-title":"J Leukoc Biol"},{"key":"R41-20260813","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease.","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"R42-20260813","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/00365521.2017.1281435","article-title":"CCR5 expression in inflammatory bowel disease and its correlation with inflammatory cells and \u03b2-arrestin2 expression.","volume":"52","author":"Ye","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R43-20260813","doi-asserted-by":"crossref","first-page":"849","DOI":"10.17219\/acem\/68846","article-title":"CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.","volume":"27","author":"Koper","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"R44-20260813","doi-asserted-by":"crossref","first-page":"101479","DOI":"10.1016\/j.xcrm.2024.101479","article-title":"CXCL9\/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.","volume":"5","author":"Lim","year":"2024","journal-title":"Cell Rep Med"},{"issue":"Pt B","key":"R45-20260813","doi-asserted-by":"crossref","first-page":"113260","DOI":"10.1016\/j.intimp.2024.113260","article-title":"Demethylzeylasteral alleviates inflammation and colitis via dual suppression of NF-\u03baB and STAT3\/5 by targeting IKK\u03b1\/\u03b2 and JAK2.","volume":"142","author":"Wen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R46-20260813","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymthe.2023.12.010","article-title":"Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity.","volume":"32","author":"Luan","year":"2024","journal-title":"Mol Ther"},{"key":"R47-20260813","doi-asserted-by":"crossref","first-page":"e002045","DOI":"10.1136\/jitc-2020-002045","article-title":"CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.","volume":"9","author":"Marcovecchio","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R48-20260813","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 a target for novel cancer therapy.","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"R49-20260813","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s12094-023-03126-4","article-title":"Targeting CXCL9\/10\/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.","volume":"25","author":"Pan","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"R50-20260813","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1038\/s41598-024-55944-3","article-title":"Identified S100A9 as a target for diagnosis and treatment of ulcerative colitis by bioinformatics analysis.","volume":"14","author":"Tan","year":"2024","journal-title":"Sci Rep"},{"key":"R51-20260813","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ecco-jcc\/jjac191","article-title":"Bidirectional Mendelian randomisation analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis.","volume":"17","author":"Chen","year":"2023","journal-title":"J Crohns Colitis"},{"key":"R52-20260813","doi-asserted-by":"crossref","first-page":"e23068","DOI":"10.1096\/fj.202300573R","article-title":"Therapy of autoimmune inflammation in sporadic amyotrophic lateral sclerosis: dimethyl fumarate and H-151 downregulate inflammatory cytokines in the cGAS-STING pathway.","volume":"37","author":"Zamiri","year":"2023","journal-title":"FASEB J"},{"key":"R53-20260813","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/JS9.0000000000002002","article-title":"Association between bariatric surgery and outcomes of total joint arthroplasty: a meta-analysis.","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:05:05Z","timestamp":1786633505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":53,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042988","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}